Page 67 - பல்கலைக்கழகம் கல்லூரி லண்டன் மருத்துவமனைகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Medicine to prevent patients from developing COVID-19 tested in UK Scientists hope that people wouls be protected from COVID-19 for a period of between six months and one year LONDON, December 26. /TASS/. A medicine that can potentially prevent people exposed to novel coronavirus from developing COVID-19 is now being tested in the United Kingdom, the Guardian reported on its website Friday. The medicine, based on monoclonal antibodies created in a laboratory, was developed by UK-Swedish pharmaceutical company AstraZeneca and the University College London Hospitals. If we can prove that this treatment works and prevent people who are exposed to the virus going on to develop Covid-19, it would be an exciting addition to the arsenal of weapons being developed to fight this dreadful virus, said Dr Catherine Houlihan, a UCLH virologist who is leading a study into the drug.

United kingdomCity ofCatherine houlihanUniversity college london hospitalsUnited kingdom swedishUniversity college londonஒன்றுபட்டது கிஂக்டம்நகரம் ஆஃப்கேத்தரின் ஹொலின்பல்கலைக்கழகம் கல்லூரி லண்டன் மருத்துவமனைகள்ஒன்றுபட்டது கிஂக்டம் ஸ்விட்ச்பல்கலைக்கழகம் கல்லூரி லண்டன்